To Evaluate the Safety, Tolerability, and Pharmacokinetics Profile in Healthy Chinese Volunteers of TG-2349

NCT03610867 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Chinese Volunteers

Interventions

DRUG: Furaprevir capsule (SAD)
DRUG: Furaprevir capsule (MAD)
DRUG: Placebo (SAD)
DRUG: Placebo (MAD)

Sponsor

Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.

Collaborators

[object Object]